Allurion Technologies (NASDAQ: ALUR) is a medical device company that develops and sells a swallowable, procedure-free intragastric balloon system for weight loss. Revenue comes from transactional sales of the Allurion Smart Capsule to distributors and health care providers, who then deliver the Allurion Program to patients. The Allurion Program pairs the capsule with remote patient support and monitoring tools as a holistic weight management platform. As of the 10-K filed March 30, 2026, the company reported commercial experience across more than 200,000 patients treated. Allurion received FDA approval for the device in February 2026 following submission of the fourth and final module of its PMA in June 2025. The company operates as a single segment, headquartered in Natick, Massachusetts, where it also maintains manufacturing space. Operating activities used $42.3 million of cash in the year ended December 31, 2024, against a net loss of $7.2 million for that period.

Revenue model

Transactional product sales of the Allurion Smart Capsule to distributors and health care providers. No subscription or recurring revenue model is described in the filing excerpts.

Products and services

Allurion Smart Capsule (swallowable intragastric balloon); Allurion Program (holistic weight loss program including remote patient support and monitoring tools).

Customers and end markets

Direct customers are distributors and health care providers. End patients are individuals seeking non-surgical weight loss. The program is designed for delivery across multiple medical specialties, not limited to gastroenterologists or surgeons.

Value-chain role

Medical device manufacturer and program developer. Sells finished devices to distributors and health care providers who deliver treatment to patients. Maintains manufacturing and warehouse space in Natick and Hudson, Massachusetts.

Geographic exposure

Headquartered in Natick, Massachusetts. Operations subject to GDPR indicate commercial presence or data processing in the European Economic Area and United Kingdom. Specific country-level revenue breakdown not disclosed in filing excerpts.

Source: SEC 10-K, filed 2026-03-30

Industry: Surgical & Medical Instruments & Apparatus Peers: Beachbody Company Inc Carriage Services Inc CHW ACQUISITION CORP European Wax Center, Inc. XWELL Inc Regis Corp WW International Inc